Skip Navigation

Cardiovascular Research 2007 76(3):418-429; doi:10.1016/j.cardiores.2007.08.005
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Casini, S.
Right arrow Articles by Veldkamp, M. W.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Casini, S.
Right arrow Articles by Veldkamp, M. W.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2007, European Society of Cardiology

Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4–S5 linker in slow inactivation

Simona Casinia, Hanno L. Tana,b, Zahurul A. Bhuiyanc, Connie R. Bezzinaa, Phil Barnetta, Elisabetta Cerbaid, Alessandro Mugellid, Arthur A.M. Wildeb and Marieke W. Veldkampa,*

aHeart Failure Research Center, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
bDepartment of Cardiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
cDepartment of Clinical Genetics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
dDepartment of Preclinical and Clinical Pharmacology, Center of Molecular Medicine, University of Florence, Florence, Italy

*Corresponding author. Academic Medical Center, University of Amsterdam, Department of Clinical and Experimental Cardiology, Heart Failure Research Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. Tel.: +31 20 5663269; fax: +31 20 6975458. m.w.veldkamp{at}amc.uva.nl

Objective Mutations in SCN5A, the gene encoding the {alpha}-subunit of the cardiac sodium channel (Nav1.5), have been associated with various inherited arrhythmia syndromes, including Brugada syndrome (BrS). Here, we report the functional consequences of a novel missense SCN5A mutation, G1319V, identified in a BrS patient. The G1319V mutation is located in the loop connecting transmembrane segments 4 and 5 in domain III (DIIIS4–S5), a region so far considered to be exclusively involved in fast inactivation.

Methods Whole-cell mutant (G1319V) and wild-type (WT) sodium currents (INa) were studied in the Human Embryonic Kidney cell line (HEK-293) transfected with Nav1.5 {alpha}-subunit cDNA (WT or mutant) together with hβ1-subunit cDNA, using the patch-clamp technique.

Results Maximal peak INa and persistent sodium current were similar in WT and channel G1319V channels. The G1319V mutation shifted the potential of half-maximal (V1/2) activation towards more positive potentials (+3.7 mV), thereby increasing the degree of depolarization required for activation. The V1/2 of inactivation of G1319V channels was shifted by –6.0 mV compared to WT, resulting in a reduced channel availability. The change in the steady-state inactivation was completely due to a negative shift (–6.8 mV) of the voltage-dependence of slow inactivation, while the voltage-dependence of fast inactivation was unaffected. The fast component of recovery from inactivation of G1319V channels was slowed down. Finally, the G1319V mutation caused a two-fold increase in the propensity of the channels to enter the slow inactivated state. Reduction in INa peak amplitude on repetitive depolarizations at short interpulse intervals (40 ms) was significantly more pronounced in G1319V compared to WT. Accordingly, carriers of the G1319V mutation showed marked QRS widening upon increases in heart rate during exercise testing, pointing to enhancement of slow inactivation.

Conclusions We identified the DIIIS4–S5 linker as a new region involved in slow inactivation of Nav1.5. The biophysical alterations of the G1319V mutation all contribute to a reduction in INa, in line with the proposed mechanism underlying BrS.

KEYWORDS Arrhythmia (mechanisms); ECG; Membrane currents; Na channel; Sudden death


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Physiol.Home page
B. W. Jarecki, P. L. Sheets, J. O. Jackson II, and T. R. Cummins
Paroxysmal extreme pain disorder mutations within the D3/S4-S5 linker of Nav1.7 cause moderate destabilization of fast inactivation
J. Physiol., September 1, 2008; 586(17): 4137 - 4153.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.